Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-Remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04570670
What this trial is testing

Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Banner Life Sciences LLC 50
Not applicableLooking for participantsNCT06864936
What this trial is testing

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
University of Maryland, Baltimore 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06330077
What this trial is testing

Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis

Who this might be right for
Multiple SclerosisRemitting Relapsing Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 60
Large-scale testing (Phase 3)Study completedNCT01917019
What this trial is testing

A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Remittent ProgressiveMultiple Sclerosis, Primary ProgressiveRelapsing-Remitting Multiple Sclerosis+2 more
Biogen 101
Not applicableStudy completedNCT00859482
What this trial is testing

Differential Immune Effects of Natalizumab

Who this might be right for
Multiple Sclerosis, Relapsing Remitting
Cantonal Hospital of St. Gallen 27
Not applicableLooking for participantsNCT07360977
What this trial is testing

Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)

Who this might be right for
PARKINSON DISEASE (Disorder)Multiple Sclerosis (MS) - Relapsing-remittingPediatric Patients Affected by Neuromuscolar and Degenerative Diseases
IRCCS Centro Neurolesi Bonino Pulejo 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03846219
What this trial is testing

MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Immunic AG 210
Large-scale testing (Phase 3)Study completedNCT00509145
What this trial is testing

Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,106
Testing effectiveness (Phase 2)Study completedNCT02280876
What this trial is testing

Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Universidad Austral de Chile 30
Post-approval studies (Phase 4)Active Not RecruitingNCT03535298
What this trial is testing

Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
The Cleveland Clinic 800
Post-approval studies (Phase 4)Looking for participantsNCT04480853
What this trial is testing

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 30
Not applicableStudy completedNCT01142583
What this trial is testing

A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 192
Not applicableActive Not RecruitingNCT06413602
What this trial is testing

The Synergistic Effects of AIH and FES in Persons With MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Shirley Ryan AbilityLab 40
Not applicableStudy completedNCT05663853
What this trial is testing

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
LAPIX Therapeutics Inc. 137
Testing effectiveness (Phase 2)Study completedNCT01717664
What this trial is testing

Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
RedHill Biopharma Limited 18
Post-approval studies (Phase 4)Study completedNCT02373098
What this trial is testing

Fingolimod Effect on Cytokine and Chemokine Levels

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 126
Post-approval studies (Phase 4)Study completedNCT01498887
What this trial is testing

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 347
Not applicableNot Yet RecruitingNCT07827586
What this trial is testing

Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Hoffmann-La Roche 1,800
Not applicableStudy completedNCT02914964
What this trial is testing

Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Terry L. Wahls 95
Not applicableStudy completedNCT02776072
What this trial is testing

Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis
Biogen 2,978
Next Page